LONDON, UK—-29th April 2010—-New Publications. Today VacZine Analytics releases a new publication investigating the epidemiology and burden of the hospital pathogen Clostridium difficile in “Rest of World” and emerging markets. The publication continues the longstanding company interest in C.diff and takes a further step to understanding the impact of the pathogen globally.DiseaseINFOPACK: [...]
Archive of posts filed under the New publications category.
VacZine Analytics releases MarketVIEW: Pseudomonas aeruginosa vaccines
LONDON, UK—-29th April 2010—-New Publications. Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for Pseudomonas aeruginosa vaccines MarketVIEW: Pseudomonas aeruginosa vaccines models the global market for a vaccine to prevent life-threatening infections from this problematic hospital pathogen. The product gives a comprehensive vaccine value [...]
VacZine Analytics releases MarketVIEW: Staphylococcus aureus vaccines
LONDON, UK—-4th March 2010—-New Publications. Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for Staphylococcus aureus vaccines MarketVIEW: Staphylococcus aureus vaccines models the global market for this potentially lucrative new vaccine category now being prioritized by most major vaccine manufacturers. The product gives a comprehensive vaccine value [...]
VacZine Analytics releases two new studies: C.diff in China and US MenACWY vaccine forecast
LONDON, UK—-1st December 2009—-New Publications. Two new research products have been now published by strategic research consultancy VacZine Analytics. The first, DiseaseINFOPACK: Clostridium difficile in China continues the longstanding company interest in C.diff and takes the first step to understanding the pathogen in large emerging economies.
The second new product, MarketVIEW: meningitis ACWY vaccines models the [...]